Julie M. Collins & James L. Gulley. (2019). Product review: Avelumab, an anti-PD-L1 antibody. Taylor & Francis Group.
Chicago Style (17th ed.) CitationJulie M. Collins and James L. Gulley. Product Review: Avelumab, an Anti-PD-L1 Antibody. Taylor & Francis Group, 2019.
MLA (9th ed.) CitationJulie M. Collins and James L. Gulley. Product Review: Avelumab, an Anti-PD-L1 Antibody. Taylor & Francis Group, 2019.
Warning: These citations may not always be 100% accurate.